[ Price : $8.95]
Federal Register Notice: FDA determines the regulatory review period for Amylin Pharmaceutcals Byetta for the purpose of patent ex...[ Price : $8.95]
FDA grants a priority review for a GlaxoSmithKline supplemental NDA for its anticoagulant product Arixtra to be used for treating ...[ Price : $8.95]
FDA approves Boston Scientifics Latitude Patient Management System to be used with all of the companys implantable defibrillators ...[ Price : $8.95]
FDA dirty tricks against two small medical device companies and the agencys growing policy of silence when challenged are the subj...[ Price : $8.95]
A federal judge approves a consent decree between FDA and BET Pharm calling for the company to destroy unapproved new drugs it com...[ Price : $8.95]
FDA approves Meridian Medical Technologies Duodote for use in treating civilians exposed to nerve poisoning agents such as sarin o...[ Price : $8.95]
FDAs continuing struggle with how it releases safety information on marketed drugs is seen in 9/29 events related to Bayers Trasyl...[ Price : $8.95]
FDA sends Medtronic its second Warning Letter in less than 30 days.